RxDoctor Payments Data

Chetan Gujrathi, MD

Otolaryngology · Phoenix, AZNPI 1669442141

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Inspire Medical Systems, Inc. accounts for 63.4% of it on its own, with 22 other manufacturers making up the rest.

$2,953in general payments, 2019–2025

Across 117 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • GSK$207
  • Sanofi$141
  • Regeneron Healthcare Solutions, Inc.$126
  • Sanofi-aventis U.S. LLC$90
  • Optinose US, Inc.$78
  • plus $441 from 17 others

What the payments were for

  • Food & beverage$2,86397%
  • Education$903%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,953 in reported general payments places this provider in the 70th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona

Medicare billing

Part B allowed, 2024
$230,538
Medicare patients
465
Services billed
1,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl89$3,104
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth21$2,311
Ipratropium Bromide57$1,548
Gabapentin59$1,127
Pentoxifylline16$1,072
Fluticasone Propionate62$895
Dexamethasone62$862
Montelukast Sodium114$856
Omeprazole38$763
Cefdinir12$538
Lidocaine Hcl ViscousLidocaine Hcl74$531
Triamcinolone Acetonide21$506
Calcitriol26$461
Chlorhexidine Gluconate115$430
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$405

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →